Showing results (131-140 of 153) with videos related to
Sort By:
Pageof 16
Experimental Cell Research|February 25, 1997
Inhibition of ICE-related proteases (caspases) and nuclear apoptosis by phenylarsine oxideA Takahashi, P J Goldschmidt-Clermont, E S Alnemri, et al.Biochemical and Biophysical Research Communications|October 23, 1996
Granzyme B/perforin-mediated apoptosis of Jurkat cells results in cleavage of poly(ADP-ribose) polymerase to the 89-kDa apoptotic fragment and less abundant 64-kDa fragmentC J Froelich, W L Hanna, G G Poirier, et al.Chromosoma|July 17, 2001
Human INCENP colocalizes with the Aurora-B/AIRK2 kinase on chromosomes and is overexpressed in tumour cellsR R Adams, D M Eckley, P Vagnarelli, et al.Developmental Cell|December 13, 2001
Scc1/Rad21/Mcd1 is required for sister chromatid cohesion and kinetochore function in vertebrate cellsE Sonoda, T Matsusaka, C Morrison, et al.The Journal of Cell Biology|October 8, 1998
Transition from caspase-dependent to caspase-independent mechanisms at the onset of apoptotic executionK Samejima, S Toné, T J Kottke, et al.Cancer Research|July 26, 2000
Down-regulation of HP1Hsalpha expression is associated with the metastatic phenotype in breast cancerD A Kirschmann, R A Lininger, L M Gardner, et al.Chromosoma|August 20, 1997
Centromeric inactivation in a dicentric human Y;21 translocation chromosomeA M Fisher, L Al-Gazali, T Pramathan, et al.Journal of Cell Science|February 1, 1993
Molecular cloning of a human homologue of Drosophila heterochromatin protein HP1 using anti-centromere autoantibodies with anti-chromo specificityW S Saunders, C Chue, M Goebl, et al.Proceedings of the National Academy of Sciences of the United States of America|August 6, 1996
Cleavage of lamin A by Mch2 alpha but not CPP32: multiple interleukin 1 beta-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosisA Takahashi, E S Alnemri, Y A Lazebnik, et al.British Journal of Cancer|October 29, 2014
Mutant PIK3CA controls DUSP1-dependent ERK 1/2 activity to confer response to AKT target therapyA Sathe, F Guerth, M V Cronauer, et al.Pageof 16